XUHC.DE vs. 2B70.DE
XUHC.DE (Xtrackers MSCI USA Health Care UCITS ETF 1D) and 2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) are both Health & Biotech Equities funds - XUHC.DE tracks the MSCI USA Health Care while 2B70.DE tracks the Nasdaq Biotechnology. Both are passively managed. Over the past 5 years, XUHC.DE returned 6.62%/yr vs 5.68%/yr for 2B70.DE. A 0.70 correlation means they provide meaningful diversification when combined. XUHC.DE charges 0.12%/yr vs 0.35%/yr for 2B70.DE.
Performance
XUHC.DE vs. 2B70.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XUHC.DE achieves a -1.34% return, which is significantly lower than 2B70.DE's 4.53% return.
XUHC.DE
- 1D
- 2.83%
- 1M
- 5.33%
- YTD
- -1.34%
- 6M
- -1.08%
- 1Y
- 12.33%
- 3Y*
- 3.62%
- 5Y*
- 6.62%
- 10Y*
- —
2B70.DE
- 1D
- 3.29%
- 1M
- 0.58%
- YTD
- 4.53%
- 6M
- 4.05%
- 1Y
- 39.50%
- 3Y*
- 10.00%
- 5Y*
- 5.68%
- 10Y*
- —
XUHC.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XUHC.DE Xtrackers MSCI USA Health Care UCITS ETF 1D | -1.34% | 1.47% | 8.81% | -0.83% | 2.49% | 36.78% | 3.35% | 24.45% | 9.04% | 1.32% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 4.53% | 18.62% | 4.60% | 2.56% | -6.29% | 7.59% | 14.52% | 30.18% | -7.35% | 2.65% |
Correlation
The correlation between XUHC.DE and 2B70.DE is 0.67, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.67 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.61 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.64 |
Correlation (All Time) Calculated using the full available price history since Nov 24, 2017 | 0.70 |
The correlation between XUHC.DE and 2B70.DE has been stable across timeframes, ranging from 0.61 to 0.70 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XUHC.DE vs. 2B70.DE — Risk / Return Rank
XUHC.DE
2B70.DE
XUHC.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI USA Health Care UCITS ETF 1D (XUHC.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XUHC.DE | 2B70.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.19 | ||
| Sortino ratioReturn per unit of downside risk | -1.54 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.34 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.10 | 6.15 | -5.06 |
| Martin ratioReturn relative to average drawdown | 2.69 | 17.06 | -14.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XUHC.DE | 2B70.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.85 | 2.04 | -1.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.45 | 0.28 | +0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.56 | 0.36 | +0.21 |
Drawdowns
XUHC.DE vs. 2B70.DE - Drawdown Comparison
The maximum XUHC.DE drawdown since its inception was -26.87%, smaller than the maximum 2B70.DE drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for XUHC.DE and 2B70.DE.
Loading charts...
Drawdown Indicators
| XUHC.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.87% | -30.87% | +4.00% |
Max Drawdown (1Y)Largest decline over 1 year | -11.18% | -6.33% | -4.85% |
Max Drawdown (3Y)Largest decline over 3 years | -22.19% | -29.34% | +7.15% |
Max Drawdown (5Y)Largest decline over 5 years | -22.19% | -30.87% | +8.68% |
Current DrawdownCurrent decline from peak | -7.48% | -1.26% | -6.22% |
Average DrawdownAverage peak-to-trough decline | -5.08% | -10.01% | +4.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.57% | 2.29% | +2.28% |
Volatility
XUHC.DE vs. 2B70.DE - Volatility Comparison
The current volatility for Xtrackers MSCI USA Health Care UCITS ETF 1D (XUHC.DE) is 5.19%, while iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a volatility of 6.65%. This indicates that XUHC.DE experiences smaller price fluctuations and is considered to be less risky than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XUHC.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.19% | 6.65% | -1.46% |
Volatility (6M)Calculated over the trailing 6-month period | 10.17% | 14.26% | -4.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.51% | 19.09% | -4.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.42% | 20.34% | -5.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.13% | 21.76% | -5.63% |
XUHC.DE vs. 2B70.DE - Expense Ratio Comparison
XUHC.DE has a 0.12% expense ratio, which is lower than 2B70.DE's 0.35% expense ratio.
Dividends
XUHC.DE vs. 2B70.DE - Dividend Comparison
XUHC.DE's dividend yield for the trailing twelve months is around 1.28%, while 2B70.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XUHC.DE Xtrackers MSCI USA Health Care UCITS ETF 1D | 1.28% | 1.29% | 1.21% | 1.86% | 1.63% | 0.82% | 1.13% | 0.96% | 0.55% |
Frequently Asked Questions
XUHC.DE and 2B70.DE have a correlation of 0.67, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XUHC.DE is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XUHC.DE is cheaper with a 0.12% expense ratio, compared with 0.35% for 2B70.DE.
XUHC.DE tracks MSCI USA Health Care, while 2B70.DE tracks Nasdaq Biotechnology. They also come from different issuers: Xtrackers and iShares. Their fees differ too: 0.12% for XUHC.DE and 0.35% for 2B70.DE.
Find the right allocation for XUHC.DE and 2B70.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer